Sharma Anuj K, Schultz Jason W, Prior John T, Rath Nigam P, Mirica Liviu M
Department of Chemistry, Washington University , One Brookings Drive, St. Louis, Missouri 63130-4899, United States.
Department of Chemistry and Biochemistry, University of Missouri St. Louis , One University Boulevard, St. Louis, Missouri 63121-4400, United States.
Inorg Chem. 2017 Nov 20;56(22):13801-13814. doi: 10.1021/acs.inorgchem.7b01883. Epub 2017 Nov 7.
Positron emission tomography (PET) is emerging as one of the most important diagnostic tools for brain imaging, yet the most commonly used radioisotopes in PET imaging, C and F, have short half-lives, and their usage is thus somewhat limited. By comparison, the Cu radionuclide has a half-life of 12.7 h, which is ideal for administering and imaging purposes. In spite of appreciable research efforts, high-affinity copper chelators suitable for brain imaging applications are still lacking. Herein, we present the synthesis and characterization of a series of bifunctional compounds (BFCs) based on macrocyclic 1,4,7-triazacyclononane and 2,11-diaza3.3pyridinophane ligand frameworks that exhibit a high affinity for Cu ions. In addition, these BFCs contain a 2-phenylbenzothiazole fragment that is known to interact tightly with amyloid β fibrillar aggregates. Determination of the protonation constants (pK values) and stability constants (log β values) of these BFCs, as well as characterization of the isolated copper complexes using X-ray crystallography, electron paramagnetic resonance spectroscopy, and electrochemical studies, suggests that these BFCs exhibit desirable properties for the development of novel Cu PET imaging agents for Alzheimer's disease.
正电子发射断层扫描(PET)正逐渐成为脑成像最重要的诊断工具之一,然而PET成像中最常用的放射性同位素碳(C)和氟(F)半衰期较短,因此其应用在一定程度上受到限制。相比之下,铜(Cu)放射性核素的半衰期为12.7小时,这对于给药和成像来说非常理想。尽管进行了大量研究,但仍缺乏适用于脑成像应用的高亲和力铜螯合剂。在此,我们报道了一系列基于大环1,4,7-三氮杂环壬烷和2,11-二氮杂3.3吡啶并环配体骨架的双功能化合物(BFCs)的合成与表征,这些化合物对铜离子具有高亲和力。此外,这些BFCs含有一个2-苯基苯并噻唑片段,已知该片段能与淀粉样β纤维聚集体紧密相互作用。对这些BFCs的质子化常数(pK值)和稳定常数(log β值)的测定,以及使用X射线晶体学、电子顺磁共振光谱和电化学研究对分离出的铜配合物进行表征,表明这些BFCs对于开发用于阿尔茨海默病的新型铜PET成像剂具有理想的性质。